Cargando…
Model-Predicted Impact of ECG Monitoring Strategies During Bedaquiline Treatment
BACKGROUND: The M2 metabolite of bedaquiline causes QT-interval prolongation, making electrocardiogram (ECG) monitoring of patients receiving bedaquiline for drug-resistant tuberculosis necessary. The objective of this study was to determine the relationship between M2 exposure and Fridericia-correc...
Autores principales: | van Beek, Stijn W, Tanneau, Lénaïg, Meintjes, Graeme, Wasserman, Sean, Gandhi, Neel R, Campbell, Angie, Viljoen, Charle A, Wiesner, Lubbe, Aarnoutse, Rob E, Maartens, Gary, Brust, James C M, Svensson, Elin M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420883/ https://www.ncbi.nlm.nih.gov/pubmed/36043179 http://dx.doi.org/10.1093/ofid/ofac372 |
Ejemplares similares
-
Relationship between Plasma and Intracellular Concentrations of Bedaquiline and Its M2 Metabolite in South African Patients with Rifampin-Resistant Tuberculosis
por: Ngwalero, Precious, et al.
Publicado: (2021) -
Effectiveness and Cardiac Safety of Bedaquiline-Based Therapy for Drug-Resistant Tuberculosis: A Prospective Cohort Study
por: Brust, James C M, et al.
Publicado: (2021) -
Population Pharmacokinetics of Delamanid and its Main Metabolite DM-6705 in Drug-Resistant Tuberculosis Patients Receiving Delamanid Alone or Coadministered with Bedaquiline
por: Tanneau, Lénaïg, et al.
Publicado: (2022) -
Understanding the drug exposure–response relationship of bedaquiline to predict efficacy for novel dosing regimens in the treatment of multidrug‐resistant tuberculosis
por: Tanneau, Lénaïg, et al.
Publicado: (2020) -
Exposure–safety analysis of QTc interval and transaminase levels following bedaquiline administration in patients with drug‐resistant tuberculosis
por: Tanneau, Lénaïg, et al.
Publicado: (2021)